In this article, we examine how three leading players — Medtronic MDT, IQVIA IQV and GE HealthCare Technologies GEHC — are ...
By tightly integrating cost, quality, and outcomes data, and deploying AI with a human-centered philosophy, Mayo Clinic is using analytics not just to manage margins, but to quicken clinical discovery ...
Practicing physician and health system AI leader brings frontline and enterprise perspective to Brim Analytics' ...
Analysis published in the American Society of Nephrology highlighted strong evidence that ERAs benefit chronic kidney disease ...
Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional ...
Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.
Background IBD is characterised by recurrent flares, but evidence on whether modifiable dietary factors influence flare risk ...
The Punch on MSNOpinion
Clinical governance, patient safety and the urgency of now
Nigeria establishes a national taskforce on clinical governance and patient safety to combat poor quality care, reduce ...
Daniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence, is now worth $7.6 billion as his AI search tool surges in ...
Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
Tenaya Therapeutics recently outlined its 2026 priorities, including updates on its TN-201 and TN-401 cardiac gene therapy programs and the resumption of patient enrollment in key Phase 1b/2 trials ...
A study using agentic artificial intelligence to detect early signs of cognitive decline in unstructured m | Mass General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results